Exchange: NASDAQ·Updated 03:47 PM EDT
PTIX logo

PTIX Protagenic Therapeutics Inc

$1.00
$0.05
(4.76%)
Today
Mkt Cap$1.9M
Vol10,691.00

About PTIX

Protagenic Therapeutics, Inc. operates as a biotechnology company. The firm engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. It offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
51

Neutral Sentiment

How do you feel about PTIX?

Advertisement|Remove ads.